4 unknown, 3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 2, 3 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 1, Not yet recruiting 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Wei Jiang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma Adebrelimab, Temozolomide, Procedure:Hyperbaric Oxygen Therapy - Glioblastoma | Phase 2 | Not yet recruiting | Wei Jiang | 94 | 2026-10-01 | 2026-08-27 |
| Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Gemcitabine,Cisplatin, Intensity-modulated radiation therapy (IMRT), Cisplatin - Nasopharyngeal Carcinoma | Phase 3 | Recruiting | Wei Jiang | 440 | 2022-11-11 | 2023-05-03 |
| Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma Camrelizumab, Gemcitabine, Induction Cisplatin - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Wei Jiang | 200 | 2022-04-06 | 2023-03-23 |
| Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma Apatinib mesylate tablet, PD-1 - Nasopharyngeal Carcinoma | Phase 2 | Completed | Wei Jiang | 25 | 2021-01-14 | 2023-01-13 |
| Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma Hypofraction radiation, Standard dose IMRT - Nasopharyngeal Carcinoma | Not applicable | Completed | Wei Jiang | 30 | 2018-07-13 | 2023-08-03 |
| Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma Apatinib mesylate tablet, Intensity-modulated radiation therapy (IMRT), Cisplatin - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Wei Jiang | 240 | 2018-07-01 | 2018-08-02 |
| Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma Demethylated drug decitabine - Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | Unknown | Wei Jiang | 30 | 2018-02-28 | 2018-10-10 |
| Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Docetaxel,Cisplatin,Fluorouracil, Intensity-modulated radiation therapy (IMRT), Cisplatin - Nasopharyngeal Carcinoma | Phase 3 | Unknown | Wei Jiang | 440 | 2015-03-01 | 2018-05-16 |
| Omega 3 for Treatment of Depression in Patients With Heart Failure 2:1 EPA/DHA, High EPA, Placebo - Depression | Phase 3 | Completed | Wei Jiang | 108 | 2014-05-01 | 2018-05-14 |
Nasopharyngeal Carcinoma (7) · Depression (1) · Glioblastoma (1)
Radiotherapy, Intensity-Modulated (5) · Cisplatin (3) · Gemcitabine (2) · apatinib (2) · CF regimen (1) · Docetaxel (1) · Temozolomide (1) · camrelizumab (1) · spartalizumab (1)
China (7) · United States (1)
Bin Zhang, M.D. (1) · Jian Zhang, M.D. (1) · Yi-xin Su, M.D. (1) · Yu-fei Pan, M.D. (1)
PMID 30098961, PMID 34817851, PMID 37480994, PMID 38239359, PMID 38329737
R34MH097034 (1)